arsenic trioxide has been researched along with sirolimus in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 9 (64.29) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bonapace, L; Bornhauser, BC; Bourquin, JP; Cario, G; Lindholm, D; Martinez, R; Niggli, FK; Schäfer, BW; Schrappe, M | 1 |
| Brossart, P; Fröhlich, E; Wahl, R | 1 |
| Chai, L; Cheng, M; Ren, Y; Wang, S; Xie, Y | 1 |
| Bhuta, S; Ding, B; Huang, J; Liu, N; Sun, Y; Tai, S; Thor, RK | 1 |
| Cavenee, WK; Cloughesy, TF; Iwanami, A; Mischel, PS | 1 |
| Annis, MG; Dong, Z; Guilbert, C; Mann, KK; Miller, WH; Siegel, PM | 1 |
| Banfic, H; Dembitz, V; Lalic, H; Ostojic, A; Visnjic, D; Vrhovac, R | 1 |
| Ge, JB; Liu, XB; Qian, JY; Shen, L; Sun, AJ; Wu, YZ; Yang, W; Yin, JS | 1 |
| Bi, Y; Chen, H; Fang, S; Hu, S; Kou, J; Li, T; Ma, R; Mo, H; Novakovic, VA; Shi, J; Wang, J; Wang, L; Yang, X; Yu, B; Zhang, Y; Zhou, J | 1 |
| Du, R; He, F; Huang, J; Huang, Y; Ma, X; Qiu, J; Wang, G; Wang, Y; Yang, D; Zhao, Y; Zhou, T | 1 |
| Guo, Q; Manthari, RK; Sun, Z; Wang, J; Yang, K; Yuan, M; Zhao, Y | 1 |
| Dion, GR; Jacobsen, C; Johnson, CM; Luke, AS; Novak, N | 1 |
2 review(s) available for arsenic trioxide and sirolimus
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
State of the Science in Tracheal Stents: A Scoping Review.
Topics: Adult; Alloys; Animals; Arsenic Trioxide; Cats; Dogs; Doxycycline; Humans; Magnesium; Mice; Mitomycin; Paclitaxel; Polydioxanone; Polyesters; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polytetrafluoroethylene; Polyurethanes; Rats; Sheep; Silicones; Sirolimus; Steel; Stents; Swine; Tracheal Stenosis | 2022 |
1 trial(s) available for arsenic trioxide and sirolimus
| Article | Year |
|---|---|
Nine-month angiographic and two-year clinical follow-up of novel biodegradable-polymer arsenic trioxide-eluting stent versus durable-polymer sirolimus-eluting stent for coronary artery disease.
Topics: Aged; Arsenic Trioxide; Arsenicals; Coronary Angiography; Coronary Artery Disease; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Oxides; Percutaneous Coronary Intervention; Polymers; Sirolimus | 2015 |
11 other study(ies) available for arsenic trioxide and sirolimus
| Article | Year |
|---|---|
Bibliography. Current world literature. Therapeutic modalities.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Dacarbazine; Genetic Therapy; Heat-Shock Proteins; Humans; Immunotherapy; Interferons; Oxides; Radiotherapy; Sirolimus; Temozolomide; Vitamin D | 2003 |
Low-dose arsenic trioxide sensitizes glucocorticoid-resistant acute lymphoblastic leukemia cells to dexamethasone via an Akt-dependent pathway.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; bcl-Associated Death Protein; Blotting, Western; Caspases; Cell Line, Tumor; Cell Survival; Dexamethasone; Drug Resistance, Neoplasm; Drug Synergism; Glucocorticoids; Humans; Neoplasm, Residual; Oxides; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Remission Induction; RNA, Small Interfering; Signal Transduction; Sirolimus; Transfection; X-Linked Inhibitor of Apoptosis Protein | 2007 |
Induction of iodide uptake in transformed thyrocytes: a compound screening in cell lines.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Boronic Acids; Bortezomib; Carcinoma; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Iodides; Lovastatin; Neoplasm Metastasis; Oxides; Pyrazines; Sirolimus; Thymus Gland; Thyroid Neoplasms; Tretinoin | 2009 |
Autophagy modification augmented the treatment effects initiated by arsenic trioxide in NB4 cells.
Topics: Adenine; Antibiotics, Antineoplastic; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Cell Line, Tumor; Cell Survival; Flow Cytometry; Humans; Leukemia, Promyelocytic, Acute; Oxides; Sirolimus | 2011 |
Arsenic trioxide synergizes with everolimus (Rad001) to induce cytotoxicity of ovarian cancer cells through increased autophagy and apoptosis.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arsenic Trioxide; Arsenicals; Autophagy; Caspase 3; Caspase 7; Cell Cycle Proteins; Cell Line, Tumor; Drug Synergism; Everolimus; Female; Humans; Immunosuppressive Agents; Mice; Mice, SCID; Ovarian Neoplasms; Oxides; Phosphoproteins; Proto-Oncogene Proteins c-akt; Sirolimus; Xenograft Model Antitumor Assays | 2012 |
Arsenic reverses glioblastoma resistance to mTOR-targeted therapies.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Brain Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Glioblastoma; Humans; Leukemia, Promyelocytic, Acute; Oxides; Quinazolines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases | 2013 |
Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; Humans; Mice; Oxides; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Sirolimus; Xenograft Model Antitumor Assays | 2013 |
The mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15;17) translocation.
Topics: Aged; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle; Cell Line, Tumor; Cell Survival; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Drug Synergism; Female; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitogen-Activated Protein Kinases; Oxides; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Translocation, Genetic | 2015 |
Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy.
Topics: Adolescent; Adult; Animals; Apoptosis; Arsenic Trioxide; Autophagy; Cell Line, Tumor; Disease Models, Animal; Drug Synergism; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Mice, SCID; Middle Aged; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Reactive Oxygen Species; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Burden; Young Adult | 2018 |
Arsenic Trioxide-Coated Stent Is an Endothelium-Friendly Drug Eluting Stent.
Topics: Adenosine Triphosphate; Animals; Arsenic Trioxide; Cell Proliferation; Cell Survival; Drug-Eluting Stents; Endothelium, Vascular; Graft Occlusion, Vascular; Male; Myocytes, Smooth Muscle; Rabbits; Sirolimus; Stents; Swine | 2018 |
Arsenic-induced autophagy regulates apoptosis in AML-12 cells.
Topics: Adenine; Animals; Apoptosis; Apoptosis Regulatory Proteins; Arsenic Trioxide; Autophagy; Cell Line; Cell Survival; Mice; Microtubule-Associated Proteins; Sirolimus | 2021 |